Flash Finance

Shalby LimitedSHALBYCorporate

Healthcare Latest results: Jun 2026 15 quarters of data
Consolidated Standalone
₹128.95
MCap ₹1,384 Cr · P/E 12.3
Shalby Limited — Stock analysis & AI research Shalby Limited — Seasonality — best & worst months Shalby Limited — Technical setup — score, trend, support & resistance Shalby Limited — Live exchange announcements
📋 High Promoter Holding Stocks 📈 MACD Bearish Crossover📈 20-Day Breakdown Stocks📈 Lowest Technical Score📈 Multi-Timeframe Bearish Stocks📈 Stocks Near 52-Week Low 🏭 Healthcare sector
AI-assisted data: figures and text on this page are extracted from public quarterly filings with AI assistance, checked automatically and overseen by our editorial team (human in the loop). They may still contain errors or omissions. Verify critical numbers against official company / SEBI / NSE / BSE filings before making any decision. Educational information only, not financial advice.
₹254 Cr
Sales · Jun 2026
+7.2% YoY
₹42 Cr
Operating Profit · Jun 2026
-9.3% YoY
16.7%
OPM % · Jun 2026
-15.7% YoY
₹25 Cr
Net Profit · Jun 2026
-2.4% YoY
₹2.33
EPS · Jun 2026
-2.5% YoY

📝 Shalby Limited — results explained

Quarter ended June 2026 (Q1 FY27)

Shalby Limited reported revenue of ₹254 crore for the quarter ended June 2026 (Q1 FY27), up 7.2% from ₹237 crore in the same quarter last year, and up 12.8% sequentially over the March 2026 quarter.

Net profit fell 2.4% year-on-year to ₹25 crore, from ₹26 crore. Earnings per share (EPS) came in at ₹2.33.

Operating profit stood at ₹42 crore — an operating margin (OPM) of 16.7%, compared with 19.8% in the year-ago quarter.

Full year and trailing twelve months

For the full year FY26, Shalby Limited posted revenue of ₹901 crore, a growth of 3.3% over FY25, with a net profit of ₹113 crore (up 36.0% year-on-year).

On a trailing-twelve-month (TTM) basis, revenue stands at ₹918 crore with a net profit of ₹113 crore.

Valuation snapshot

At the current price of ₹128.95, SHALBY has a market capitalisation of ₹1,384 crore and a trailing P/E of about 12.3.

Within the Healthcare industry, it is the 11th-largest of the 22 companies we track by market value.

Shareholding pattern

As of Sep 2026, promoters held 74.33%, foreign institutional investors (FIIs) 4.65%, domestic institutional investors (DIIs) 0.31%, public shareholders 20.08% of Shalby Limited.

📈 Share price & events

📊 Quarterly trend

₹ crore · OPM % on right axis

🎯 Key metrics

price-linked ratios use the latest close
Valuation
Market Cap ?
₹1,384 Cr
Current Price ?
₹128.9
P/E ?
12.29below ind
Industry P/E ?
34.70
P/B ?
1.11
P/S ?
1.51
P/FCF ?
76.87
Enterprise Value ?
₹1,515 Cr
EV/EBITDA ?
10.66
PEG ?
0.95
Earnings Yield ?
6.6%
Dividend Yield ?
0.00%
Profitability & Returns
Sales (TTM) ?
₹918 Cr
OPM ?
15.5%
Profit after tax (TTM) ?
₹113 Cr
EPS (TTM) ?
₹10.50
ROCE ?
10.0%
ROE ?
9.0%
ROA ?
7.1%
Growth
Sales — latest qtr ?
₹254 Cr
PAT — latest qtr ?
₹25 Cr
YoY qtr sales growth ?
7.2%
YoY qtr profit growth ?
-2.4%
Sales growth (3y) ?
8%
Sales growth (5y) ?
17%
Profit growth (3y) ?
13%
Profit growth (5y) ?
21%
Financial Health
Debt ?
₹131 Cr
Debt to Equity ?
0.11
Interest Coverage ?
8.5
Current Ratio ?
N/A
Ownership
Promoter holding ?
74.33%
Change in promoter holding ?
0.06%
Pledged percentage ?
N/A
Market
Return 3 months ?
-21.4%
Return 6 months ?
-19.9%

🗓️ Quarterly results (15 quarters · ₹ Cr)

same fiscal quarter as Jun bestweakest per row · for costs (interest, NPAs) low is best
Metric Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026 YoY % QoQ %
Sales 176177211217195206233212221207237224215225254 +7.2% +12.8%
Operating Profit 353044524338513543314739303142 -9.3% +37.1%
Other Income 465654856766655 -4.5% +5.5%
Interest 111111333334423 +19.1% +53.8%
Depreciation 999999101010101010101111 +11.6% -1.8%
Profit Before Tax 292640473833462836264031222334 -15.5% +47.3%
Net Profit 191826302523301721152620145425 -2.4% -53.6%
EPS 1.791.702.442.832.302.092.841.611.941.392.391.841.284.972.33 -2.5% -53.1%
OPM % 19.8% 16.9% 21.1% 23.7% 22.1% 18.4% 21.7% 16.5% 19.3% 14.9% 19.8% 17.4% 13.8% 13.8% 16.7% -15.7% +21.0%

📆 Annual results (₹ Cr, FY = Apr–Mar)

Metric FY25 FY26 TTM YoY %
Sales ₹872 Cr ₹901 Cr ₹918 Cr +3.3%
Operating Profit ₹159 Cr ₹146 Cr ₹142 Cr -7.8%
OPM % 18.21% 16.26% 15.48% -10.7%
NPM % 9.55% 12.57% 12.27% +31.6%
Other Income ₹26 Cr ₹22 Cr ₹22 Cr -14.7%
Depreciation ₹39 Cr ₹41 Cr ₹42 Cr +3.8%
Interest ₹11 Cr ₹12 Cr ₹13 Cr +8.7%
EBIT ₹120 Cr ₹106 Cr ₹100 Cr -11.6%
PBT ₹135 Cr ₹116 Cr ₹109 Cr -14.6%
Tax ₹41 Cr ₹33 Cr ₹28 Cr -18.8%
Net Profit ₹83 Cr ₹113 Cr ₹113 Cr +36.0%
EPS ₹7.78 ₹10.48 ₹10.42 +34.7%
Material Cost ₹402 Cr ₹10 Cr ₹170 Cr -97.5%
Employee Cost ₹82 Cr ₹83 Cr ₹86 Cr +1.3%
Extraordinary Items — — — —

🏛️ Balance Sheet (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Equity Capital 107107107108 +0.9%
Reserves 8639551,0271,139 +10.9%
Borrowings 34121110131 +19.1%
Other Liabilities 163192226216 -4.4%
Total Liabilities 1,1671,3761,4701,595 +8.5%
Fixed Assets 603599579621 +7.3%
CWIP 10580 -100.0%
Investments 313511599623 +4.0%
Other Assets 242260284350 +23.2%
Total Assets 1,1671,3761,4701,595 +8.5%

💧 Cash Flow (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Cash from Operating Activity 16514014991 -38.9%
Cash from Investing Activity -172-206-101-109 -7.9%
Cash from Financing Activity -3872-369 +125.0%
Net Cash Flow -46612-8 -166.7%
Free Cash Flow 16211012618 -85.7%
CFO/OP 134%89%99%89% -10.1%

➗ Ratios (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Debtor Days 46525573 +32.7%
Cash Conversion Cycle 46525573 +32.7%
Working Capital Days 353837142 +283.8%
ROCE % 13%14%12%10% -16.7%

👥 Shareholding (latest 5 periods)

Metric Jun 2025Sep 2025Dec 2025Mar 2026Sep 2026 % Chg
Promoters 74.27%74.33%74.33%74.33%74.33% +0.0%
FIIs 5.21%4.63%4.47%4.36%4.65% +6.7%
DIIs 0.19%0.19%0.19%0.25%0.31% +24.0%
Public 19.65%20.18%20.36%20.41%20.08% -1.6%
Others 0.69%0.66%0.66%0.66%— —
No. of Shareholders 53,43753,78452,49551,41550,572 -1.6%

⚖️ Peer comparison

Industry: Healthcare · 22 companies · full page →
# Company CMP MCap (Cr) P/E Sales TTM NP TTM OPM% NPM% Sales YoY% NP YoY% Qtr Rev Δ% Qtr NP Δ%
1 VIJAYA Vijaya Diagnostic ₹1,507.80 15,530 82.7 857 187 42.3% 21.8% 19.5% 20.2% 22.8% 37.3%
2 METROPOLIS Metropolis Healthcare ₹596.30 12,370 61.1 1,710 203 24.7% 11.9% 23.6% 31.4% 16.6% 25.7%
3 HCG Healthcare Global ₹704.05 10,512 390.9 2,626 33 18.2% 1.3% 14.6% -53.3% 13.1% 175.3%
4 YATHARTH Yatharth Hospital ₹988.90 9,528 54.1 1,200 171 23.6% 14.3% 36.2% 31.6% 47.6% 16.2%
5 JLHL Jupiter Life ₹277.85 9,109 9.7 1,557 187 22.1% 12.0% 20.9% -6.7% 18.2% -14.5%
6 THYROCARE Thyrocare Technologies ₹555.45 8,841 50.0 876 176 32.1% 20.1% 20.8% 79.4% 24.3% 33.2%
7 KOVAI Kovai Medical ₹6,260.50 6,850 26.7 1,644 256 27.9% 15.6% 15.7% 16.7% 15.3% 20.6%
8 INDRAMEDCO Indraprastha Medical ₹363.20 3,330 17.7 1,524 188 18.0% 12.4% 9.3% 13.7% 11.3% 9.5%
9 KRSNAA Krsnaa Diagnostics ₹543.40 1,763 18.1 816 98 26.8% 12.0% 7.8% 31.0% 22.1% -19.3%
10 SURAKSHA Suraksha Diagnostic ₹311.85 1,624 45.3 325 35 31.4% 10.8% 23.1% 1.4% 20.7% 40.0%
11 SHALBY Shalby ₹132.15 1,418 38.0 1,176 37 12.1% 3.2% 5.0% 1683.0% 11.7% 36.7%
12 GPTHEALTH GPT Healthcare ₹157.90 1,296 27.4 491 48 18.5% 9.8% 15.1% -21.9% 17.8% 62.5%
13 LAXMIDENTL Laxmi Dental ₹196.21 1,080 35.0 287 31 16.2% 10.9% 16.0% -10.1% 13.2% 28.9%
14 NEPHROCARE Nephro Care ₹234.80 387 — — — — — — — 68.4% 347.7%
15 LOTUSEYE Lotus Eye ₹114.50 243 n/m 57 0 8.5% 0.3% 8.4% -89.1% 26.2% 13.0%
16 UNIHEALTH Unihealth Hospitals ₹121.00 190 6.5 132 46 40.9% 34.8% — — 104.6% 71.5%
17 MADHAVBAUG Vaidya Sane ₹148.00 156 19.1 147 8 11.4% 5.6% — — 116.1% 94.3%
18 MHHL Mohini Health ₹57.05 104 — 145 -17 -1.4% -11.7% — — -6.6% -1400.0%
19 MAITREYA Maitreya Medicare ₹120.65 82 — 45 -2 -1.0% -5.5% — — -5.2% -1720.0%
20 AATMAJ Aatmaj Healthcare ₹26.75 60 83.6 24 1 9.7% 2.9% — — 22.5% -39.4%
21 NIDAN Nidan Laborator. ₹33.00 46 30.6 26 2 19.0% 5.9% — — -11.2% -92.0%
22 ARTEMISMED Artemis Medicare ₹315.00 — 48.0 1,081 103 17.4% 9.6% 15.4% 25.9% 16.3% 30.9%
❓ Frequently asked questions
What was Shalby Limited's revenue in Q1 FY27?
Shalby Limited reported revenue of ₹254 crore for the quarter ended June 2026 (Q1 FY27), up 7.2% from ₹237 crore in the same quarter last year, and up 12.8% sequentially over the March 2026 quarter.
What was Shalby Limited's net profit in Q1 FY27?
Net profit fell 2.4% year-on-year to ₹25 crore, from ₹26 crore. Earnings per share (EPS) came in at ₹2.33.
What is SHALBY's market capitalisation and P/E ratio?
At the current price of ₹128.95, SHALBY has a market capitalisation of ₹1,384 crore and a trailing P/E of about 12.3.
Who owns Shalby Limited? (shareholding pattern)
As of Sep 2026, promoters held 74.33%, foreign institutional investors (FIIs) 4.65%, domestic institutional investors (DIIs) 0.31%, public shareholders 20.08% of Shalby Limited.
TTM ends 2026-06-30. Amounts are ₹ crore unless stated otherwise. Figures are extracted by AI from public quarterly filings; gaps are filled from public market data. Live price refreshed about twice a day from exchange data. Educational information only — not financial advice.
⚠️ How this site is made: Market data pages are computed automatically from NSE/BSE publications and company filings; news articles and announcement analyses are written with AI assistance, with a human in the loop: our editors review what the AI produces. Both can contain errors. Verify with the original sources before any investment decision. Not investment advice; Flash Finance is not SEBI-registered. How we use AI